insights_auto
Why is CUE down 39,29%?
Dive Deeperchevron_right
CUE:NASDAQ
Cue Biopharma Inc
8,56 $
arrow_downward
-39,29%(-5,54) 1D
17 қар., 10:39:50 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CUE...
Open
13,02 $
High
13,52 $
Low
7,65 $
Mkt. cap
62,18 млн
Avg. vol.
164,99 м.
Volume
357,35 м.
52-wk high
45,50 $
52-wk low
4,97 $
EPS
-26,99 $
Beta
2,79
Shares outstanding
7,26 млн
No. of employees
29
Open
13,02 $
High
13,52 $
Low
7,65 $
Mkt. cap
62,18 млн
Avg. vol.
164,99 м.
Volume
357,35 м.
52-wk high
45,50 $
52-wk low
4,97 $
EPS
-26,99 $
Beta
2,79
Shares outstanding
7,26 млн
No. of employees
29
News stories
From web sources and news partners
Benzinga
·
29 минут бұрын
Dow Falls Over 200 Points; US Retail Sales Rise 0.2% In October
GuruFocus
·
15 сағат бұрын
Cue Biopharma Reports Q3 2026: Revenue Hits $0.1 Million, Net Loss Per Share of $4.74 Misses Estimates
Investing.com
·
16 сағат бұрын
Cue Biopharma earnings missed by $3.39, revenue fell short of estimates
Yahoo Finance
·
17 сағат бұрын
Cue Biopharma Reports Third Quarter 2026 Financial Results and Recent Business Highlights
About Cue Biopharma Inc
CEO-
Employees29
Founded2014
HeadquartersБостон, Массачусетс, Америка Құрама Штаттары
SectorHealth Care
Industry-
Websitecuebiopharma.com